Financials data is unavailable for this security.
View more
Year on year LifeMD Inc grew revenues 28.15% from 119.03m to 152.55m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -45.54m to -20.60m.
| Gross margin | 89.64% |
|---|---|
| Net profit margin | -11.49% |
| Operating margin | -10.01% |
| Return on assets | -39.18% |
|---|---|
| Return on equity | -- |
| Return on investment | -240.82% |
More ▼
Cash flow in USDView more
In 2023, LifeMD Inc increased its cash reserves by 737.26%, or 29.19m. Cash Flow from Financing totalled 29.10m or 19.08% of revenues. In addition the company generated 8.82m in cash from operations while cash used for investing totalled 8.73m.
| Cash flow per share | -0.412 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -0.1847 |
|---|---|
| Tangible book value per share | -0.561 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.8254 |
|---|---|
| Quick ratio | 0.7805 |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | 1.49 |
More ▼
